Skip to content

Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension

Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05845905
Enrollment
158
Registered
2023-05-06
Start date
2023-05-10
Completion date
2024-12-31
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Brief summary

The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.

Detailed description

Current studies have shown that remote ischemic conditioning can improve vascular endothelial function and inhibit sympathetic nervous system activity. Thus it may provide some organ protection as well as anti-hypertensive effects. The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.

Interventions

PROCEDURERemote ischemic conditioning

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by the inflation of an automated cuff to the pressure rising by 20 mmHg from baseline systolic pressure. RIC will be conducted twice daily for 7 days.

PROCEDURESham remote ischemic conditioning

Sham-RIC is performed in the same way as the treatment group except that the blood pressure cuff is inflated to 60 mmHg, which produces mild pressure sensations but has no blocking impact on blood flow.

Sponsors

Yi Yang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 1\) Age ≥65 years and ≤85 years, regardless of gender; * 2\) History of essential hypertension and clinical systolic blood pressure ≥ 140 mmHg, regardless of whether they are receiving antihypertensive medication; * 3\) Willing to participate and sign the informed consent.

Exclusion criteria

* 1\) Secondary hypertension; * 2\) Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg; * 3\) Severe organ dysfunction or failure; * 4\) Severe hematologic disorders or significant coagulation abnormalities; * 5\) History of atrial fibrillation or myocardial infarction within 6 months; * 6\) Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc; * 7\) Individuals who will or have received anticoagulant therapy with drugs such as dabigatran, rivaroxaban, warfarin, etc; * 8\) Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment; * 9\) Other conditions that the researchers think are not suitable for the project.

Design outcomes

Primary

MeasureTime frameDescription
Mean systolic blood pressure0-7 daysDifference in mean value of systolic blood pressure during RIC/sham-RIC between two groups.

Secondary

MeasureTime frameDescription
Mean diastolic blood pressure0-7 daysDifference in mean value of diastolic blood pressure during RIC/sham-RIC between two groups.

Countries

China

Contacts

Primary ContactYi Yang, MD, PhD
doctor_yangyi@163.com13756661217
Backup ContactZhen-Ni Guo, MD, PhD
zhen1ni2@163.com18186872986

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026